MedWatch

ALK finds replacement for long-time North America lead

Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.

Nearly 23 years as head of the US at ALK have come to end for Jorge Alderete, who is retiring effective June 30 | Photo: ALK / PR

After nearly 23 years at helm of ALK North America, Jorge Alderete will step down as president of the Danish allergy firm’s US subsidiary effective June 30, he writes in a post on LinkedIn.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs